Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
The lab will facilitate the development of herbal and natural-based solutions
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The company showcased three core programs developed through this platform
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
Offers affordable, high-quality solutions for diabetes care
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Subscribe To Our Newsletter & Stay Updated
